Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Ecnoglutide

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Hangzhou Sciwind Biosciences Co · Phase 1/2 · Recruiting · Enrollment 126

NCT07243171

ArmPopulationDoseWeeksEstimandWeight change
oral ecnoglutide dose 1Obesity or overweightn/rn/rn/rn/r
oral ecnoglutide dose 2Obesity or overweightn/rn/rn/rn/r
oral ecnoglutide dose 3Obesity or overweightn/rn/rn/rn/r
oral ecnoglutide dose 4Obesity or overweightn/rn/rn/rn/r
placebo dose 1Obesity or overweightn/rn/rn/rn/r
placebo dose 2Obesity or overweightn/rn/rn/rn/r